— Know what they know.
Not Investment Advice

PZRXQ OTC

PhaseRx, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -95.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 51 · $1169 mcap · 12M float · 0.0020% daily turnover

Balance Sheet Trends

Total Assets
$16M +320.2% ▲
Total Liabilities
$7M -86.5% ▼
Shareholders Equity
$9M +119.0% ▲
Cash & Investments
$15M +370.5% ▲
Total Debt
$6M -71.3% ▼
Net Debt
-$4M -125.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2014FY2015FY2016
— Assets —
Cash$2M$3M$10M
Short-Term Investments$0$0$5M
Cash & ST Investments$2M$3M$15M
Net Receivables$0$0$0
Inventory$0$0$0
Other Current Assets$0$0$0
Total Current Assets$2M$4M$16M
Property, Plant & Equip.$453K$236K$271K
Goodwill & Intangibles$0$0$0
Long-Term Investments$0$0$0
Other Non-Current Assets$0$0$0
Total Non-Current Assets$453K$236K$271K
Total Assets$3M$4M$16M
— Liabilities —
Accounts Payable$197K$396K$515K
Short-Term Debt$13M$20M$576K
Deferred Revenue$375K$0$0
Other Current Liabilities$2M$3M$252K
Total Current Liabilities$16M$24M$2M
Long-Term Debt$0$0$5M
Other Non-Current Liab.$28M$29M$0
Total Non-Current Liabilities$28M$29M$5M
Total Liabilities$44M$53M$7M
— Equity —
Common Stock$2K$2K$1K
Retained Earnings-$42M-$49M-$69M
Accumulated OCI$0$0$3K
Total Stockholders Equity-$42M-$49M$9M
Total Liabilities & Equity$3M$4M$16M
— Key Metrics —
Total Debt$13M$20M$6M
Net Debt$11M$17M-$4M
Total Investments$0$0$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms